Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sean Jeffrey Dangelmajer, M.D.

Title
Institution
Department
Address

Biography
Johns Hopkins UniversityBABiology
Stanford University School of MedicineMDDoctor of Medicine
Massachusetts General HospitalAnesthesiology Resident

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Li M, Zeng L, Liu S, Dangelmajer S, Kahlert UD, Huang H, Han Y, Chi X, Zhu M, Lei T. Transforming Growth Factor-ß Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma. J Neuropathol Exp Neurol. 2019 Apr 01; 78(4):315-325. PMID: 30863846.
    Citations:    
  2. Li M, Sun S, Dangelmajer S, Zhang Q, Wang J, Hu F, Dong F, Kahlert UD, Zhu M, Lei T. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma. Stem Cell Res Ther. 2019 03 12; 10(1):88. PMID: 30867058.
    Citations:    
  3. Bishop JA, Dangelmajer S, Corcoran-Schwartz I, Gardner MJ, Routt MLC, Castillo TN. Bilateral Sacral Ala Fractures Are Strongly Associated With Lumbopelvic Instability. J Orthop Trauma. 2017 Dec; 31(12):636-639. PMID: 29189523.
    Citations:    
  4. Dangelmajer S, Yang A, Githens M, Harris AHS, Bishop JA. Disparities in Total Hip Arthroplasty Versus Hemiarthroplasty in the Management of Geriatric Femoral Neck Fractures. Geriatr Orthop Surg Rehabil. 2017 Sep; 8(3):155-160. PMID: 28835872.
    Citations:    
  5. Dangelmajer S, Familiari F, Simonetta R, Kaymakoglu M, Huri G. Meniscal Transplants and Scaffolds: A Systematic Review of the Literature. Knee Surg Relat Res. 2017 Mar 01; 29(1):3-10. PMID: 28231642.
    Citations:    
  6. Zhu M, Li M, Zhou Y, Dangelmajer S, Kahlert UD, Xie R, Xi Q, Shahveranov A, Ye D, Lei T. Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo. Br J Anaesth. 2016 Jun; 116(6):870-7. PMID: 27199319.
    Citations:    
  7. Pan J, Connolly ID, Dangelmajer S, Kintzing J, Ho AL, Grant G. Sports-related brain injuries: connecting pathology to diagnosis. Neurosurg Focus. 2016 Apr; 40(4):E14. PMID: 27032917.
    Citations:    
  8. Auvergne R, Wu C, Connell A, Au S, Cornwell A, Osipovitch M, Benraiss A, Dangelmajer S, Guerrero-Cazares H, Quinones-Hinojosa A, Goldman SA. PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo. Oncogene. 2016 07 21; 35(29):3817-28. PMID: 26616854.
    Citations:    
  9. Feng Y, Zhu M, Dangelmajer S, Lee YM, Wijesekera O, Castellanos CX, Denduluri A, Chaichana KL, Li Q, Zhang H, Levchenko A, Guerrero-Cazares H, Quiñones-Hinojosa A. Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis. 2015 Jun 25; 6:e1797. PMID: 26111059.
    Citations:    
  10. Zhu M, Feng Y, Dangelmajer S, Guerrero-Cázares H, Chaichana KL, Smith CL, Levchenko A, Lei T, Quiñones-Hinojosa A. Human cerebrospinal fluid regulates proliferation and migration of stem cells through insulin-like growth factor-1. Stem Cells Dev. 2015 Jan 15; 24(2):160-71. PMID: 25265906.
    Citations:    
  11. Feng Y, Zhu M, Dangelmajer S, Lee YM, Wijesekera O, Castellanos CX, Denduluri A, Chaichana KL, Li Q, Zhang H, Levchenko A, Guerrero-Cazares H, Quiñones-Hinojosa A. Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis. 2014 Dec 11; 5:e1567. PMID: 25501828.
    Citations:    
  12. Dangelmajer S, Zadnik PL, Rodriguez ST, Gokaslan ZL, Sciubba DM. Minimally invasive spine surgery for adult degenerative lumbar scoliosis. Neurosurg Focus. 2014 May; 36(5):E7. PMID: 24785489.
    Citations: 9     Fields:    Translation:Humans
  13. Chaichana KL, Rao K, Gadkaree S, Dangelmajer S, Bettegowda C, Rigamonti D, Weingart J, Olivi A, Gallia GL, Brem H, Lim M, Quinones-Hinojosa A. Factors associated with survival and recurrence for patients undergoing surgery of cerebellar metastases. Neurol Res. 2014 Jan; 36(1):13-25. PMID: 24070068.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dangelmajer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.